The Lancet Oncology最新文献

{"title":"Correction to Lancet Oncol 2025; 26: 629–40","authors":"","doi":"10.1016/s1470-2045(25)00541-8","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00541-8","url":null,"abstract":"<em>Kuemmel S, Graeser M, Schmid P, et al. Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial.</em> Lancet Oncol <em>2025; <strong>26:</strong> 629–40</em>—In this Article, the first sentence of the fifth paragraph of the Discussion section should have read “Our translational research suggests that higher baseline expression of <em>ERBB2</em>, <em>PD-1</em>, and <em>PD-L1</em>, and ctDNA negativity are associated with pathological complete response after neoadjuvant pembrolizumab plus dual HER2 blockade.” This correction has been made to the online version as of Sept 29, 2025.","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"141 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thoracic multiple meningiomas mimicking mesothelioma","authors":"Wei Guo, Kun Wang","doi":"10.1016/s1470-2045(25)00439-5","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00439-5","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Contributors</h2>WG did the literature search, followed the patient, and collected her medical information. KW drafted the manuscript, selected the images, and revised the manuscript. Both authors read and approved the final version. Written informed consent to publication was obtained.</section></section><section><section><h2>Declaration of interests</h2>We declare no competing interests.</section></section>","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"WHO calls for investment in cancer prevention and care within a wider NCD strategy","authors":"Paul Adepoju","doi":"10.1016/s1470-2045(25)00591-1","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00591-1","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cancer care in urgent demand in Ukraine, says WHO","authors":"Sharmila Devi","doi":"10.1016/s1470-2045(25)00590-x","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00590-x","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prostate cancer screening bill before NZ Parliament","authors":"Karl Gruber","doi":"10.1016/s1470-2045(25)00557-1","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00557-1","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145083998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Spanish Government approves proposed tobacco law","authors":"Manjulika Das","doi":"10.1016/s1470-2045(25)00556-x","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00556-x","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145083916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"WHO updates Lists of Essential Medicines","authors":"Talha Burki","doi":"10.1016/s1470-2045(25)00549-2","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00549-2","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145043380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Delay to England's National Cancer Plan could cost lives","authors":"Elizabeth Gourd","doi":"10.1016/s1470-2045(25)00551-0","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00551-0","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"132 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145043233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ghana announces free childhood cancer treatment plans","authors":"Paul Adepoju","doi":"10.1016/s1470-2045(25)00550-9","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00550-9","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145043121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2025 World Conference on Lung Cancer","authors":"David Collingridge","doi":"10.1016/s1470-2045(25)00548-0","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00548-0","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>ARROS-1 study: new ROS1 TKI</h2>Speaking on behalf of a large international group of researchers, Alexander Drilon (Memorial Sloan Kettering Cancer Center, New York, NY, USA) showed that zidesamtinib, a next-generation ROS1 tyrosine kinase inhibitor (TKI), has clinically meaningful activity in patients with CNS disease, with ROS1 G2032R mutations, or in those who have exhausted all other available treatment options. In a large phase 1/2 trial, 432 patients were recruited. 50% of patients had received previous ROS1 TKIs</section></section><section><section><h2>NADIM ADJUVANT trial</h2>Interim results from a Spanish phase 3 trial suggest adjuvant chemo-immunotherapy reduces recurrence in patients with completely resected stage IB–IIIA non-small-cell lung cancer (NSCLC) and has an acceptable safety profile, according to Mariano Provencio (Universidad Autónoma de Madrid, Madrid, Spain). 206 patients from 30 hospitals in Spain were randomly assigned to receive either adjuvant chemotherapy (carboplatin plus paclitaxel) followed by observation or to the same chemotherapy plus</section></section><section><section><h2>Best screening age for lung cancer?</h2>The UK Lung Cancer Screening programme screens people up to 74 years of age. Other countries have different age limits. Given more cancers are detected at older age, Patrick Goodley (University of Manchester, Manchester, UK) and colleagues did a study to look at the trade-offs of extending the upper age limit for screening. Using data from the Yorkshire Lung Screening Trial and the North &amp; East Manchester Lung Health Check programme, 574 cases of lung cancer were diagnosed: 384 in a 55–74 years</section></section><section><section><h2>Tobacco, radon, and air pollution</h2>Effective population-based lung cancer screening relies on increasing cost-effectiveness, improving risk stratification to identify high-risk individuals, and better understanding of the disease aetiology. Data from &lt;18 000 participants enrolled into two screening programmes, show a potential role for polygenic risk scores (PRS) and ambient air pollution, specifically exposure to PM_2·5. Lianne Trap (Erasmus University Medical Centre, Rotterdam, the Netherlands), on behalf of Dutch and Belgian</section></section>","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145043120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}